株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ヒトマイクロバイオームの世界市場の分析と予測:製品、疾病、用途、地域別

Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography

発行 The Insight Partners 商品コード 802185
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
ヒトマイクロバイオームの世界市場の分析と予測:製品、疾病、用途、地域別 Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease, Application, and Geography
出版日: 2019年01月28日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界のヒトマイクロバイオーム市場について調査分析を行い、市場概要、市場のダイナミクスなどについて考察するとともに、製品別、疾病別、用途別、地域別に市場を分析、主な企業のプロファイルなどについて包括的にまとめています。

第1章 イントロダクション

第2章 主な調査結果

第3章 ヒトマイクロバイオーム市場の状況

  • 市場概要
  • 市場のセグメンテーション
  • PEST分析

第4章 ヒトマイクロバイオーム市場:主な産業のダイナミクス

  • 主な市場促進因子
  • 主な市場抑制因子
  • 主な市場機会
  • 臨床試験
  • 影響分析

第5章 ヒトマイクロバイオーム市場:世界市場分析

  • 世界のヒトマイクロバイオーム市場の概要
  • 世界のヒトマイクロバイオーム市場の収益予測と分析
  • 市場ポジショニング/市場シェア
  • 主要企業の業績
  • 専門家の見解

第6章 世界のヒトマイクロバイオーム市場の収益と予測:製品別

  • 概要
  • 製品市場の収益と予測分析
  • 食品
  • 医療食品
  • プロバイオティクス
  • プレバイオティクス
  • 薬品
  • 診断デバイス
  • その他

第7章 世界のヒトマイクロバイオーム市場の収益と予測:疾病別

  • 概要
  • 疾病市場の収益と予測分析
  • 糖尿病
  • 自己免疫疾患
  • 肥満
  • 精神疾患
  • その他

第8章 世界のヒトマイクロバイオーム市場の収益と予測:用途別

  • 概要
  • 用途市場の収益と予測分析
  • 診断
  • 治療

第9章 北米のヒトマイクロバイオーム市場の収益と予測:国別分析

第10章 欧州のヒトマイクロバイオーム市場の収益と予測:国別分析

第11章 アジア太平洋地域のヒトマイクロバイオーム市場の収益と予測:国別分析

第12章 中東/アフリカのヒトマイクロバイオーム市場の収益と予測:国別分析

第13章 中南米のヒトマイクロバイオーム市場の収益と予測:国別分析

第14章 産業の状況

第15章 ヒトマイクロバイオーム市場:主要企業プロファイル

  • ENTEROME
  • MERCK & CO., INC.
  • MICROBIOME THERAPEUTICS, LLC
  • REBIOTIX INC.
  • YAKULT HONSHA CO., LTD.
  • OSEL INC.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DUPONT

第16章 付録

目次
Product Code: TIPBT00002233

The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025.

The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. However, the strict government guidelines is the major concern in the human microbiome market. The strict government guidelines are intended to hamper the market to an extent. The advancements in science and technology made the scientists excited about the potential and potency of fecal matter and the microbes in it. The cell-based therapies found a novel paradigm in drug development, a regulatory framework that reports safety and bio containment issues should be established to minimize adverse events and environmental release of engineered organisms. In recent years, for drug discovery the microbiota plays an important role in the efficacy of therapeutic compounds. There is a new phenomenon in the globe. It is the human gut microbiome and the role it may play in the future of human health. Recently various reports have indicated that the human gut microbiome may be implicated in health conditions such as obesity, metabolism, diabetes, immunity and autism.

The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.

The application segment of the human microbiome market is broadly segmented into diagnostics and therapeutics. In 2017, therapeutics segment held the largest share of the market, by application. Moreover, the therapeutics segment is expected to grow at the fastest rate during the coming years owing to the increase in digestive problems, increase in the drug-related side effects, and development of therapies for chronic diseases like cancer.

Some of the major primary and secondary sources included in the report for the human microbiome market are National Cancer Institute, National Health Service, World Health Organization, Food and Drug Administration, Public Health England, and Health Protection Agency among others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. SCOPE OF STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. HUMAN MICROBIOME MARKET LANDSCAPE

  • 3.1. MARKET OVERVIEW
  • 3.2. MARKET SEGMENTATION
    • 3.2.1. Human Microbiome Market - By Product
    • 3.2.2. Human Microbiome Market - By Disease
    • 3.2.3. Human Microbiome Market - By Application
    • 3.2.4. Human Microbiome Market - By Region
      • 3.2.4.1. By Country
  • 3.3. PEST ANALYSIS
    • 3.3.1. North America - PEST Analysis
    • 3.3.2. Europe - PEST Analysis
    • 3.3.3. Asia Pacific - PEST Analysis
    • 3.3.4. Middle East and Africa - PEST Analysis
    • 3.3.5. South and Central America- PEST Analysis

4. HUMAN MICROBIOME MARKET - KEY INDUSTRY DYNAMICS

  • 4.1. KEY MARKET DRIVERS
  • 4.2. KEY MARKET RESTRAINTS
  • 4.3. KEY MARKET OPPORTUNITIES
  • 4.4. CLINICAL TRIALS
  • 4.5. IMPACT ANALYSIS

5. HUMAN MICROBIOME MARKET - GLOBAL ANALYSIS

  • 5.1. GLOBAL HUMAN MICROBIOME MARKET OVERVIEW
  • 5.2. GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 5.3. MARKET POSITIONING/MARKET SHARE
  • 5.4. PERFORMANCE OF KEY PLAYERS
  • 5.5. EXPERT OPINIONS

6. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT

  • 6.1. OVERVIEW
  • 6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 6.3. FOODS MARKET
    • 6.3.1. Overview
    • 6.3.2. Foods Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.4. MEDICAL FOODS MARKET
    • 6.4.1. Overview
    • 6.4.2. Medical Foods Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.5. PROBIOTICS MARKET
    • 6.5.1. Overview
    • 6.5.2. Probiotics Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.6. PREBIOTICS MARKET
    • 6.6.1. Overview
    • 6.6.2. Prebiotics Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.7. DRUGS MARKET
    • 6.7.1. Overview
    • 6.7.2. Drugs Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.8. DIAGNOSTIC DEVICES MARKET
    • 6.8.1. Overview
    • 6.8.2. Diagnostic Devices Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.9. OTHER PROBIOTIC SUPPLEMENTS MARKET
    • 6.9.1. Overview
    • 6.9.2. Other Probiotic Supplements Market Revenue Forecasts and Analysis (US$ Mn)

7. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE

  • 7.1. OVERVIEW
  • 7.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 7.3. DIABETES MARKET
    • 7.3.1. Overview
    • 7.3.2. Diabetes Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.4. CANCER MARKET
    • 7.4.1. Overview
    • 7.4.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.5. AUTOIMMUNE DISORDERS MARKET
    • 7.5.1. Overview
    • 7.5.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.6. OBESITY MARKET
    • 7.6.1. Overview
    • 7.6.2. Obesity Market Revenue Forecasts and Analysis (US$ Mn
  • 7.7. MENTAL DISORDERS MARKET
    • 7.7.1. Overview
    • 7.7.2. Mental Disorders Market Revenue Forecasts and Analysis (US$ Mn
  • 7.8. OTHER DISEASES MARKET
    • 7.8.1. Overview
    • 7.8.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)

8. HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
  • 8.3. DIAGNOSTICS MARKET
    • 8.3.1. Overview
    • 8.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
  • 8.4. THERAPEUTICS MARKET
    • 8.4.1. Overview
    • 8.4.2. Therapeutics Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 9.1. NORTH AMERICA HUMAN MICROBIOME MARKET OVERVIEW
  • 9.2. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 9.3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 9.4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 9.5. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 9.6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 9.7. US MARKET OVERVIEW
    • 9.7.1. US Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.7.2. US Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.7.3. US Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 9.8. CANADA MARKET OVERVIEW
    • 9.8.1. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.8.2. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.8.3. Canada Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 9.9. MEXICO MARKET OVERVIEW
    • 9.9.1. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 9.9.2. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 9.9.3. Mexico Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 10.1. EUROPE HUMAN MICROBIOME MARKET OVERVIEW
  • 10.2. EUROPE HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 10.3. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 10.4. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 10.5. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 10.6. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 10.7. UK MARKET OVERVIEW
    • 10.7.1. UK Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.7.2. UK Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.7.3. UK Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 10.8. GERMANY MARKET OVERVIEW
    • 10.8.1. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.8.2. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.8.3. Germany Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 10.9. FRANCE MARKET OVERVIEW
    • 10.9.1. France Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 10.9.2. France Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 10.9.3. France Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn

11. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 11.1. ASIA PACIFIC HUMAN MICROBIOME MARKET OVERVIEW
  • 11.2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 11.3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 11.4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 11.5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 11.6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 11.7. JAPAN MARKET OVERVIEW
    • 11.7.1. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.7.2. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.7.3. Japan Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 11.8. CHINA MARKET OVERVIEW
    • 11.8.1. China Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.8.2. China Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.8.3. China Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 11.9. INDIA MARKET OVERVIEW
    • 11.9.1. India Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 11.9.2. India Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 11.9.3. India Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 12.1. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET OVERVIEW
  • 12.2. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 12.3. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 12.4. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 12.5. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 12.6. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 12.7. SOUTH AFRICA MARKET OVERVIEW
    • 12.7.1. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.7.2. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.7.3. South Africa Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 12.8. SAUDI ARABIA MARKET OVERVIEW
    • 12.8.1. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.8.2. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.8.3. Saudi Arabia Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)
  • 12.9. UAE MARKET OVERVIEW
    • 12.9.1. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 12.9.2. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 12.9.3. UAE Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 13.1. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET OVERVIEW
  • 13.2. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 13.3. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
  • 13.4. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
  • 13.5. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
  • 13.6. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
  • 13.7. BRAZIL MARKET OVERVIEW
    • 13.7.1. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Product (US$ Mn)
    • 13.7.2. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
    • 13.7.3. Brazil Human Microbiome Market Revenue Forecasts and Analysis - By Application (US$ Mn)

14. INDUSTRY LANDSCAPE

  • 14.1. ORGANIC GROWTH STRATEGIES
    • 14.1.1. New Product Launches
    • 14.1.2. Marketing & Promotional Activities
  • 14.2. INORGANIC GROWTH STRATEGIES
    • 14.2.1. Partnerships, Collaborations, and Joint Ventures
    • 14.2.2. Mergers & Acquisitions

15. HUMAN MICROBIOME MARKET, KEY COMPANY PROFILES

  • 15.1. ENTEROME
    • 15.1.1. Key Facts
    • 15.1.2. Business Description
    • 15.1.3. Financial Overview
    • 15.1.4. Product Portfolio
    • 15.1.5. Product Pipeline
    • 15.1.6. SWOT Analysis
    • 15.1.7. Key Developments
  • 15.2. MERCK & CO., INC.
    • 15.2.1. Key Facts
    • 15.2.2. Business Description
    • 15.2.3. Financial Overview
    • 15.2.4. Product Portfolio
    • 15.2.5. Product Pipeline
    • 15.2.6. SWOT Analysis
    • 15.2.7. Key Developments
  • 15.3. MICROBIOME THERAPEUTICS, LLC
    • 15.3.1. Key Facts
    • 15.3.2. Business Description
    • 15.3.3. Financial Overview
    • 15.3.4. Product Portfolio
    • 15.3.5. Product Pipeline
    • 15.3.6. SWOT Analysis
    • 15.3.7. Key Developments
  • 15.4. REBIOTIX INC.
    • 15.4.1. Key Facts
    • 15.4.2. Business Description
    • 15.4.3. Financial Overview
    • 15.4.4. Product Portfolio
    • 15.4.5. Product Pipeline
    • 15.4.6. SWOT Analysis
    • 15.4.7. Key Developments
  • 15.5. YAKULT HONSHA CO., LTD.
    • 15.5.1. Key Facts
    • 15.5.2. Business Description
    • 15.5.3. Financial Overview
    • 15.5.4. Product Portfolio
    • 15.5.5. Product Pipeline
    • 15.5.6. SWOT Analysis
    • 15.5.7. Key Developments
  • 15.6. OSEL INC.
    • 15.6.1. Business Description
    • 15.6.2. Financial Overview
    • 15.6.3. Product Portfolio
    • 15.6.4. Product Pipeline
    • 15.6.5. SWOT Analysis
    • 15.6.6. Key Developments
  • 15.7. Vedanta Biosciences, Inc.
    • 15.7.1. Key Facts
    • 15.7.2. Business Description
    • 15.7.3. Financial Overview
    • 15.7.4. Product Portfolio
    • 15.7.5. Product Pipeline
    • 15.7.6. SWOT Analysis
    • 15.7.7. Key Developments
  • 15.8. Metabiomics Corporate
    • 15.8.1. Key Facts
    • 15.8.2. Business Description
    • 15.8.3. Financial Overview
    • 15.8.4. Product Portfolio
    • 15.8.5. Product Pipeline
    • 15.8.6. SWOT Analysis
    • 15.8.7. Key Developments
  • 15.9. Synthetic Biologics, Inc.
    • 15.9.1. Key Facts
    • 15.9.2. Business Description
    • 15.9.3. Financial Overview
    • 15.9.4. Product Portfolio
    • 15.9.5. Product Pipeline
    • 15.9.6. SWOT Analysis
    • 15.9.7. Key Developments
  • 15.10. DUPONT
    • 15.10.1. Key Facts
    • 15.10.2. Business Description
    • 15.10.3. Financial Overview
    • 15.10.4. Product Portfolio
    • 15.10.5. Product Pipeline
    • 15.10.6. SWOT Analysis
    • 15.10.7. Key Developments

16. APPENDIX

  • 16.1. ABOUT THE INSIGHT PARTNERS
  • 16.2. GLOSSARY OF TERMS
  • 16.3. RESEARCH METHODOLOGY
Back to Top